Dr Imran Fayaz, MD in Conroe, TX - Medicare Neurosurgery

Dr Imran Fayaz, MD is a medicare enrolled "Neurological Surgery" physician in Conroe, Texas. He graduated from medical school in 1990 and has 34 years of diverse experience with area of expertise as Neurosurgery. His current practice location is 500 Medical Center Blvd Ste 222, Conroe, Texas. You can reach out to his office (for appointments etc.) via phone at (281) 880-0700.

Dr Imran Fayaz is licensed to practice in Texas (license number M1090) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1396717351.

Contact Information

	Dr Imran Fayaz, MD
	500 Medical Center Blvd Ste 222, Conroe, TX 77304-2800
	(281) 880-0700
	(281) 419-9997

Physician's Profile

Full Name	Dr Imran Fayaz
Gender	Male
Speciality	Neurosurgery
Experience	34 Years
Location	500 Medical Center Blvd Ste 222, Conroe, Texas
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Imran Fayaz graduated from medical school in 1990

NPI Data:

NPI Number: 1396717351
Provider Enumeration Date: 02/03/2006
Last Update Date: 06/15/2023

Medicare PECOS Information:

PECOS PAC ID: 9537197520
Enrollment ID: I20050801000476

Medical Identifiers

Medical identifiers for Dr Imran Fayaz such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1396717351	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207T00000X	Neurological Surgery	M1090 (Texas)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Hca Houston Healthcare Conroe	Conroe, TX	Hospital

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Imran Fayaz allows following entities to bill medicare on his behalf.

Entity Name	Imran Fayaz, M.d., P.a.
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1518196930 PECOS PAC ID: 4688729353 Enrollment ID: O20090901000489

News Archive

IT for patient care varies widely across U.S. physician practices

While there's wide enthusiasm for harnessing the power of information technology (IT) to improve U.S. medical care, fewer than a quarter of physicians in 2001 could generate electronic treatment reminders for use during patient visits and only about 10 percent could write electronic prescriptions

The U.S. FDA approves 2 drugs for treating radiation contamination

The U.S. Food and Drug Administration has approved two drugs, pentetate calcium trisodium injection (Ca-DTPA) and pentetate zinc trisodium injection (Zn-DTPA) for treating certain kinds of radiation contamination. The FDA is approving these two drugs as part of its ongoing effort to provide the American public the best available protection against nuclear accidents and terrorist threats.

Morria Biopharmaceuticals receives approval to commence its Phase II clinical trial on MRX6

Morria Biopharmaceuticals Plc, a biopharmaceutical company focusing on novel, non-steroidal anti-inflammatory drugs, announced today that it has received written approval to commence its Phase II clinical trial on its leading topical Multi-Functional Anti Inflammatory Drug (MFAID) MRX6.

Clinical Decision Support Systems help reduce unnecessary CT and MRI scans

Researchers from Virginia Mason Medical Center in Seattle, WA, have found that clinical decision support systems can help reduce inappropriate medical imaging, including unnecessary computed tomography (CT) and magnetic resonance imaging (MRI) scans, according to a study in the January issue of the Journal of the American College of Radiology (www.jacr.org).

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Imran Fayaz is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Imran Fayaz, MD Po Box 131479, The Woodlands, TX 77393-1479 Ph: (281) 779-4030	Dr Imran Fayaz, MD 500 Medical Center Blvd Ste 222, Conroe, TX 77304-2800 Ph: (281) 880-0700

News Archive

IT for patient care varies widely across U.S. physician practices

The U.S. FDA approves 2 drugs for treating radiation contamination

Morria Biopharmaceuticals receives approval to commence its Phase II clinical trial on MRX6

Clinical Decision Support Systems help reduce unnecessary CT and MRI scans

Neurological Surgery Doctors in Conroe, TX

Dr. Derek Gene Kroll, DO Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 500 Medical Center Blvd, Conroe, TX 77304 Phone: 281-719-9681
Praveen B Reddy, M.D Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1020 Riverwood Ct Ste 305, Conroe, TX 77304 Phone: 832-447-7494 Fax: 832-510-0563
David Edward Tomaszek, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 111 Vision Park Blvd, Suite 250, Conroe, TX 77384 Phone: 936-321-1130 Fax: 936-321-1230

Dr Imran Fayaz, MD - Medicare Neurosurgery in Conroe, TX

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Medicare Reassignments

IT for patient care varies widely across U.S. physician practices

The U.S. FDA approves 2 drugs for treating radiation contamination

Morria Biopharmaceuticals receives approval to commence its Phase II clinical trial on MRX6

Clinical Decision Support Systems help reduce unnecessary CT and MRI scans

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

IT for patient care varies widely across U.S. physician practices

The U.S. FDA approves 2 drugs for treating radiation contamination

Morria Biopharmaceuticals receives approval to commence its Phase II clinical trial on MRX6

Clinical Decision Support Systems help reduce unnecessary CT and MRI scans

Neurological Surgery Doctors in Conroe, TX